Global /United Kingdom /Healthcare /Drug Manufacturers - Specialty & Generic /ALRPD
chevron_leftBack
Rapid Nutrition PLC logo

Rapid Nutrition PLC

ALRPD
EPA: ALRPD Delayed
12.20EUR -3.2%
14.06 USD
As of 6 June 2026, Rapid Nutrition PLC has a market cap of $6.95M USD, ranking #43082 globally and #978 in the United Kingdom. It ranks #3813 in the Healthcare sector, and #265 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
43082
Country Rank
978
Sector Rank
3813
Industry Rank
265
Key Stats
Market Cap
$6.95MUSD
5.98M EUR
Enterprise Value
$6.37MUSD
5.53M EUR
Revenue (TTM)
$488.98KUSD
420.99K EUR
Net Income (TTM)
-$1.67MUSD
-1.43M EUR
PS Ratio
14.2
PB Ratio
6.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Simon St. Ledger open_in_new
Employees
12
Founded
2001
Website
rnplc.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.2% 15% -13% 133% 232% 114%
Upcoming Earnings
Earnings Date
Fri, Jun 26

News

Loading...

Markets

Exchange Ticker Price
Euronext Paris
MIC: XPAR
PRIMARY
ALRPD
ISIN: GB00BVVK7R18
Shares Out.:
6.21M1 Shares Float: 1.35M2
TV:
SA:
YF:
GF:
BA:
MS:
12.20 EUR
London Stock Exchange
MIC: XLON
0RNS
ISIN: GB00BVVK7R18
TV:
SA:
YF:
GF:
BA:
MS:
11.96 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Rapid Nutrition PLC

Rapid Nutrition PLC, a natural healthcare company, develops and distributes science-based health and wellness products worldwide. The company offers natural and organic ingredients designed for weight loss under the System LS brand; herbal medicine for symptoms of sore throat, colds, and flu, as well as added Ashwagandha and Andrographis for strong immunity boost for travelers under the Azurene brand. It also provides products under the third-party brands. Rapid Nutrition PLC was founded in 2001 and is based in Mildenhall, the United Kingdom.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United Kingdom)
Name
Market Cap diff.
PE
$4.01B
2.98B GBP
58K%
10.3
$875.65M
652.25M GBP
12K%
-
$721.59M
537.5M GBP
10K%
19.5
$308.67M
229.92M GBP
4K%
73.8
IMM
$35.18M
26.2M GBP
406%
-
PXS
$32.28M
24.05M GBP
364%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
542K%
24.2
$29.56B
425K%
-
$15.86B
107.34B CNY
228K%
16.0
CIPLA
$11.12B
1.06T INR
160K%
23.4
LUPIN
$11.0B
1.05T INR
158K%
22.7
$9.1B
61.6B CNY
131K%
80.6
chevron_leftBack